EI
TMO icon

Ethic Inc’s Thermo Fisher Scientific TMO Stock Holding History

Ethic Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3M Buy
48,517
+287
+0.6% +$138K 0.3% 47
2026
Q1 		$23.7M Sell
48,230
-2,221
-4% -$1.21M 0.37% 39
2025
Q4 		$29.2M Buy
50,451
+4,480
+10% +$2.53M 0.45% 28
2025
Q3 		$22.3M Buy
45,971
+4,898
+12% +$2.28M 0.37% 39
2025
Q2 		$16.8M Sell
41,073
-4,031
-9% -$1.69M 0.3% 55
2025
Q1 		$21.8M Buy
45,104
+3,102
+7% +$1.68M 0.44% 33
2024
Q4 		$21.9M Buy
42,002
+5,066
+14% +$2.79M 0.44% 29
2024
Q3 		$21.5M Sell
36,936
-1,875
-5% -$1.11M 0.54% 21
2024
Q2 		$21.5M Buy
38,811
+1,875
+5% +$1.07M 0.5% 23
2024
Q1 		$21.5M Buy
36,936
+4,391
+13% +$2.46M 0.54% 21
2023
Q4 		$17.3M Buy
32,545
+2,671
+9% +$1.29M 0.51% 23
2023
Q3 		$15.1M Buy
29,874
+1,206
+4% +$643K 0.53% 22
2023
Q2 		$15M Sell
28,668
-353
-1% -$190K 0.55% 22
2023
Q1 		$16.7M Buy
29,021
+4,451
+18% +$2.51M 0.68% 16
2022
Q4 		$13.5M Buy
24,570
+394
+2% +$209K 0.73% 16
2022
Q3 		$12.3M Buy
24,176
+1,673
+7% +$936K 0.83% 10
2022
Q2 		$12.2M Buy
22,503
+3,876
+21% +$2.13M 0.85% 11
2022
Q1 		$11M Buy
18,627
+1,875
+11% +$1.08M 0.76% 10
2021
Q4 		$11.2M Buy
16,752
+3,853
+30% +$2.41M 0.86% 10
2021
Q3 		$7.37M Buy
12,899
+1,372
+12% +$753K 0.75% 15
2021
Q2 		$5.82M Buy
11,527
+3,048
+36% +$1.44M 0.7% 21
2021
Q1 		$3.87M Buy
8,479
+3,122
+58% +$1.49M 0.69% 24
2020
Q4 		$2.5M Buy
5,357
+1,443
+37% +$677K 0.66% 24
2020
Q3 		$1.73M Buy
3,914
+1,155
+42% +$477K 0.66% 28
2020
Q2 		$1M Buy
2,759
+1,376
+99% +$461K 0.57% 37
2020
Q1 		$392K Buy
1,383
+570
+70% +$180K 0.33% 101
2019
Q4 		$264K Buy
+813
New +$247K 0.19% 173

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Ethic Inc's TMO Position: Q2 2026 in Review

Ethic Inc increased its Thermo Fisher Scientific (TMO) stake by 0.6% in Q2 2026, buying an estimated $138K and bringing the position to 48,517 shares worth $24.3M. The position accounts for 0.3% of the portfolio, ranked #47.

Ethic Inc first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $29.2M in Q4 2025. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ethic Inc held 48,517 shares of Thermo Fisher Scientific worth $24.3M as of Q2 2026.
  • Ethic Inc bought 287 Thermo Fisher Scientific shares in Q2 2026, an estimated $138K.
  • Thermo Fisher Scientific made up 0.3% of Ethic Inc's portfolio in Q2 2026, its #47 holding.
  • Ethic Inc first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Ethic Inc's Thermo Fisher Scientific position peaked at $29.2M in Q4 2025.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.